News | February 03, 2023
Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022
The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022
The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
91% of cloud leaders expect their cloud capabilities to be largely centralized within the next 2 years and 64% of cloud leaders have realized cybersecurity cost savings by migrating to cloud
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022
The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022
The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022
Subscribe To Our Newsletter & Stay Updated
